Catalyst
Slingshot members are tracking this event:
FDA Grants Priority Review to Atezolizumab - Biologics License Application Date set for September 12, 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RHHBY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 19, 2016
Occurred Source:
http://www.roche.com/media/store/releases/med-cor-2016-10-19.htm
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Atezolizumab, Metastatic Urothelial Carcinoma, Bladder Cancer, Priority Review, Biologics License Application
